Investors are always looking for stocks that are poised to beat at earnings season and Voyager Therapeutics, Inc. VYGR may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Voyager Therapeutics is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings – with the most up-to-date information possible – is a pretty good indicator of some favorable trends underneath the surface for VYGR in this report.

Analysts have very recently bumped up their estimates for VYGR, giving the stock a Zacks Earnings ESP of +13.19% heading into earnings season.

Voyager Therapeutics, Inc. Price and EPS Surprise

Voyager Therapeutics, Inc. Price and EPS Surprise | Voyager Therapeutics, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here ).

MUST READ  Earnings Reaction History: Cornerstone OnDemand Inc., 33.3% Follow-Through Indicator, 5.8% Sensitive

Given that VYGR has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see  the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .

Clearly, recent earnings estimate revisions suggest that good things are ahead for Voyager Therapeutics, and that a beat might be in the cards for the upcoming report.

Zacks Top 10 Stocks for 2018

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?

Last year’s 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp. and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2018 today >>

MUST READ  Public Service Enterprise (PEG) Misses Q3 Earnings & Sales

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Voyager Therapeutics, Inc. (VYGR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.




Please enter your comment!
Please enter your name here